RUNX2 Cancer Research Results
RUNX2, Runt-related transcription factor 2: Click to Expand ⟱
| Source: |
| Type: |
RUNX2 (Runt-related transcription factor 2) is a transcription factor that plays a crucial role in the regulation of bone development and osteoblast differentiation.
RUNX2 is overexpressed in: breast, prostate, lung, osteosarcoma.
|
Scientific Papers found: Click to Expand⟱
*NRF2↑, CA activated nuclear factor erythroid 2-related factor 2 (Nrf2) and inhibited nicotinamide adenine dinucleotide phosphate oxidase 1 (NOX1), leading to increased antioxidant enzyme activity and reduced intracellular ROS levels.
*NOX↓,
*TAC↑,
*ROS↓, CA reduces intracellular ROS via Keap1/Nrf2 signalling and increases antioxidant enzyme expression
*NQO1↑, CA treatment enhanced the expression of Nrf2 (Figs. 4C and F), and the content of NQO1
*p‑PTEN↑, CA intervention significantly upregulated p-PTEN expression
RUNX2↓, CA inhibits the expression of Runx2 and SOX9
SOX9↓,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Kinase & Signal Transduction ⓘ
SOX9↓, 1,
Proliferation, Differentiation & Cell State ⓘ
RUNX2↓, 1,
Total Targets: 2
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
NQO1↑, 1, NRF2↑, 1, ROS↓, 1, TAC↑, 1,
Proliferation, Differentiation & Cell State ⓘ
p‑PTEN↑, 1,
Cellular Microenvironment ⓘ
NOX↓, 1,
Total Targets: 6
Scientific Paper Hit Count for: RUNX2, Runt-related transcription factor 2
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:776 State#:% Dir#:1
wNotes=on sortOrder:rid,rpid
Home Page